vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and STAG Industrial, Inc. (STAG). Click either name above to swap in a different company.
STAG Industrial, Inc. is the larger business by last-quarter revenue ($224.2M vs $185.2M, roughly 1.2× AMICUS THERAPEUTICS, INC.). STAG Industrial, Inc. runs the higher net margin — 27.6% vs 0.9%, a 26.7% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 9.1%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 8.7%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Stag Arms is a firearms manufacturer founded in May 2003 and located in Cheyenne, Wyoming. Stag Arms is a manufacturer of the AR-15 type rifle, marketed as Stag-15 rifles. Stag advertises that all their weapons and accessories are made in the United States. They are best known for their left-handed AR-15 rifles, which use a mirror imaged upper receiver and have the ejection port reversed for left-handed shooters and the safety selector control on the right side of the lower receiver.
FOLD vs STAG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $224.2M |
| Net Profit | $1.7M | $62.0M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | — |
| Net Margin | 0.9% | 27.6% |
| Revenue YoY | 23.7% | 9.1% |
| Net Profit YoY | -88.5% | — |
| EPS (diluted) | $0.00 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $224.2M | ||
| Q4 25 | $185.2M | $220.9M | ||
| Q3 25 | $169.1M | $211.1M | ||
| Q2 25 | $154.7M | $207.6M | ||
| Q1 25 | $125.2M | $205.6M | ||
| Q4 24 | $149.7M | $199.3M | ||
| Q3 24 | $141.5M | $190.7M | ||
| Q2 24 | $126.7M | $189.8M |
| Q1 26 | — | $62.0M | ||
| Q4 25 | $1.7M | $83.5M | ||
| Q3 25 | $17.3M | $48.6M | ||
| Q2 25 | $-24.4M | $50.0M | ||
| Q1 25 | $-21.7M | $91.4M | ||
| Q4 24 | $14.7M | $51.0M | ||
| Q3 24 | $-6.7M | $41.9M | ||
| Q2 24 | $-15.7M | $59.8M |
| Q1 26 | — | — | ||
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | — | ||
| Q3 25 | 20.3% | — | ||
| Q2 25 | -6.1% | — | ||
| Q1 25 | -6.3% | — | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 11.8% | — |
| Q1 26 | — | 27.6% | ||
| Q4 25 | 0.9% | 37.8% | ||
| Q3 25 | 10.2% | 23.0% | ||
| Q2 25 | -15.8% | 24.1% | ||
| Q1 25 | -17.3% | 44.5% | ||
| Q4 24 | 9.8% | 25.6% | ||
| Q3 24 | -4.8% | 21.9% | ||
| Q2 24 | -12.4% | 31.5% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | $0.00 | — | ||
| Q3 25 | $0.06 | — | ||
| Q2 25 | $-0.08 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $-0.02 | — | ||
| Q2 24 | $-0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $8.9M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $3.6B |
| Total Assets | $949.9M | $7.2B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $8.9M | ||
| Q4 25 | $293.5M | $14.9M | ||
| Q3 25 | $263.8M | $17.3M | ||
| Q2 25 | $231.0M | $15.4M | ||
| Q1 25 | $250.6M | $9.3M | ||
| Q4 24 | $249.9M | $36.3M | ||
| Q3 24 | $249.8M | $70.0M | ||
| Q2 24 | $260.1M | $33.3M |
| Q1 26 | — | — | ||
| Q4 25 | $392.7M | $3.3B | ||
| Q3 25 | $392.0M | $3.1B | ||
| Q2 25 | $391.3M | $3.0B | ||
| Q1 25 | $390.7M | $3.0B | ||
| Q4 24 | $390.1M | $3.0B | ||
| Q3 24 | $389.5M | $2.9B | ||
| Q2 24 | $388.9M | $2.8B |
| Q1 26 | — | $3.6B | ||
| Q4 25 | $274.2M | $3.6B | ||
| Q3 25 | $230.4M | $3.4B | ||
| Q2 25 | $204.3M | $3.4B | ||
| Q1 25 | $193.6M | $3.5B | ||
| Q4 24 | $194.0M | $3.5B | ||
| Q3 24 | $178.8M | $3.3B | ||
| Q2 24 | $132.5M | $3.3B |
| Q1 26 | — | $7.2B | ||
| Q4 25 | $949.9M | $7.2B | ||
| Q3 25 | $868.8M | $6.9B | ||
| Q2 25 | $815.3M | $6.8B | ||
| Q1 25 | $789.8M | $6.8B | ||
| Q4 24 | $785.0M | $6.8B | ||
| Q3 24 | $786.6M | $6.6B | ||
| Q2 24 | $749.5M | $6.4B |
| Q1 26 | — | — | ||
| Q4 25 | 1.43× | 0.91× | ||
| Q3 25 | 1.70× | 0.91× | ||
| Q2 25 | 1.92× | 0.88× | ||
| Q1 25 | 2.02× | 0.87× | ||
| Q4 24 | 2.01× | 0.88× | ||
| Q3 24 | 2.18× | 0.89× | ||
| Q2 24 | 2.93× | 0.84× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | — |
| Free Cash FlowOCF − Capex | $16.0M | — |
| FCF MarginFCF / Revenue | 8.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | 3.9% |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $16.3M | $104.5M | ||
| Q3 25 | $35.7M | $143.5M | ||
| Q2 25 | $-26.5M | $111.9M | ||
| Q1 25 | $7.8M | $103.5M | ||
| Q4 24 | $-3.9M | $104.9M | ||
| Q3 24 | $-23.0M | $128.0M | ||
| Q2 24 | $22.7M | $122.2M |
| Q1 26 | — | — | ||
| Q4 25 | $16.0M | $43.8M | ||
| Q3 25 | $35.3M | $95.5M | ||
| Q2 25 | $-28.9M | $62.3M | ||
| Q1 25 | $7.5M | $57.2M | ||
| Q4 24 | $-4.2M | $37.6M | ||
| Q3 24 | $-23.3M | $86.7M | ||
| Q2 24 | $21.6M | $105.0M |
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | 19.8% | ||
| Q3 25 | 20.9% | 45.2% | ||
| Q2 25 | -18.7% | 30.0% | ||
| Q1 25 | 6.0% | 27.8% | ||
| Q4 24 | -2.8% | 18.8% | ||
| Q3 24 | -16.5% | 45.5% | ||
| Q2 24 | 17.0% | 55.3% |
| Q1 26 | — | 3.9% | ||
| Q4 25 | 0.2% | 27.4% | ||
| Q3 25 | 0.2% | 22.7% | ||
| Q2 25 | 1.6% | 23.9% | ||
| Q1 25 | 0.2% | 22.5% | ||
| Q4 24 | 0.2% | 33.8% | ||
| Q3 24 | 0.3% | 21.6% | ||
| Q2 24 | 0.9% | 9.1% |
| Q1 26 | — | — | ||
| Q4 25 | 9.62× | 1.25× | ||
| Q3 25 | 2.06× | 2.95× | ||
| Q2 25 | — | 2.24× | ||
| Q1 25 | — | 1.13× | ||
| Q4 24 | -0.27× | 2.06× | ||
| Q3 24 | — | 3.06× | ||
| Q2 24 | — | 2.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
STAG
Segment breakdown not available.
